Sopharma AD, Bulgaria’s leading pharmaceutical company, initiated an acquisition of a substantial portfolio comprising consumer healthcare and prescription products. At the end of November 2024, Sopharma announced the completion of the due diligence procedures, marking the conclusion of the first stage of the acquisition. At this juncture, an amount of EUR 40 million was disbursed. The subsequent […]
